Abstract
Genomics and proteomics have unveiled a plethora of protein-protein interactions that may control cellular processes involved in disease development. Many of these interactions involve non-traditional candidate targets (i.e., neither enzymes nor cell surface receptors / channels). To date, non-traditional targets have largely been ignored by the pharmaceutical industry or have failed to lead to drugs. This review focuses on the use of transdominant genetically encoded agents and specialized small-molecule drugs to explore this void.
Keywords: transdominant genetics, reverse genetics, protein-protein interaction, non-traditional drug target
Current Gene Therapy
Title: Non-Traditional Drug Targets: High Risk, High Reward
Volume: 3 Issue: 5
Author(s): Tanya Sandrock and Alexander Kamb
Affiliation:
Keywords: transdominant genetics, reverse genetics, protein-protein interaction, non-traditional drug target
Abstract: Genomics and proteomics have unveiled a plethora of protein-protein interactions that may control cellular processes involved in disease development. Many of these interactions involve non-traditional candidate targets (i.e., neither enzymes nor cell surface receptors / channels). To date, non-traditional targets have largely been ignored by the pharmaceutical industry or have failed to lead to drugs. This review focuses on the use of transdominant genetically encoded agents and specialized small-molecule drugs to explore this void.
Export Options
About this article
Cite this article as:
Sandrock Tanya and Kamb Alexander, Non-Traditional Drug Targets: High Risk, High Reward, Current Gene Therapy 2003; 3 (5) . https://dx.doi.org/10.2174/1566523034578212
DOI https://dx.doi.org/10.2174/1566523034578212 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature
Current Pharmaceutical Design Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry iMethylK-PseAAC: Improving Accuracy of Lysine Methylation Sites Identification by Incorporating Statistical Moments and Position Relative Features into General PseAAC via Chou’s 5-steps Rule
Current Genomics Electrolysis of Ionic Liquids. A Possible Keystone for the Achievement of Green Solvent-Catalyst Systems
Current Organic Chemistry Phytochemical and Pharmacological Insight on Sesamol: An Updated Review
Current Bioactive Compounds Automated Brain Tumor Segmentation from MRI Images using Morphometric Algorithms
Current Signal Transduction Therapy Natural-based Hydrogels: A Journey from Simple to Smart Networks for Medical Examination
Current Medicinal Chemistry Potential Role of Natural Compounds Against Skin Aging
Current Medicinal Chemistry Design of Phenotypic Screens for Bioactive Chemicals and Identification of their Targets by Genetic and Proteomic Approaches
Combinatorial Chemistry & High Throughput Screening Nasal <i>In-situ</i> Gel: An Approach to Enhance Therapeutic Benefits of the Drug
Drug Delivery Letters Applications of HPLC-MALDI-TOF MS/MS Phosphoproteomic Analysis in Oncological Clinical Diagnostics
Current Proteomics Synthesis and Biological Evaluation of 1, 3-Dihydroxyxanthone Mannich Base Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery Is Technical-Grade Chlordane an Obesogen?
Current Medicinal Chemistry Extrahepatic Metabolism may Complicate the IVIVC in Rats
Drug Metabolism Letters The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review
Current Topics in Medicinal Chemistry A Combined Cheminformatics and Computational Approach for the Prediction of Anti-HIV Small Molecules
Current Computer-Aided Drug Design Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Therapeutic Nanoparticles and Associated Toxicity
Current Nanoscience Trends in Cell-Based Electrochemical Biosensors
Current Medicinal Chemistry Biotin-Encoded and Fe<sub>3</sub>O<sub>4</sub>-Loaded Polymeric Nano Micelles: Preparation, Optimization and In Vitro Characterization
Letters in Drug Design & Discovery